Bio-Rad Laboratories Newsroom

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow JonesDec 9 08:59 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaDec 9 08:49 ET

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $481

Moomoo NewsDec 9 07:33 ET

A Quick Look at Today's Ratings for Bio-Rad Laboratories(BIO.US), With a Forecast Between $360 to $469

Moomoo NewsNov 1 09:18 ET

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow JonesOct 31 15:49 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaOct 31 15:39 ET

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $469

Moomoo NewsOct 31 07:33 ET

Citi Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $450

Moomoo NewsOct 31 07:33 ET

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $446

Moomoo NewsOct 24 22:32 ET

Bio-Rad Laboratories (BIO) Gets a Buy From RBC Capital

TipRanksOct 24 21:59 ET

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)

TipRanksOct 8 05:03 ET

Bio-Rad Upped by Citi to Buy; Charles River, Hologic Downgraded

Seeking AlphaOct 1 18:38 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaOct 1 09:27 ET

Citi Upgrades Bio-Rad Laboratories(BIO.US) to Buy Rating, Raises Target Price to $400

Moomoo NewsOct 1 06:31 ET

Nephron Initiates Bio-Rad Laboratories(BIO.US) With Buy Rating, Announces Target Price $390

Moomoo NewsAug 28 14:31 ET

Jefferies Maintains Bio-Rad Laboratories(BIO.US) With Hold Rating, Raises Target Price to $340

Moomoo NewsAug 28 06:32 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaAug 16 11:14 ET

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Maintains Target Price $401

Moomoo NewsAug 16 07:31 ET

Bio-Rad Laboratories (BIO) Receives a Buy From RBC Capital

TipRanksAug 16 06:50 ET

Bio-Rad Laboratories Analyst Ratings

BenzingaAug 2 12:23 ET